Prof. Ofer Nativ

Prof. Ofer Nativ

Urological surgeon
Head of the urology department, "Bnei Zion" Medical Center

Departments: Urology

Overview:

Prof. Ofer Nativ is graduate of Faculta de Medicina e Chirurgia, Universita de Milano, Italy.
Obtained Special training in Urology Surgery in several leading hospital around the world. Specializes in complex bladder, prostate and kidney cancer.

Education and Academic Degrees:

Since 1999: Associated Professor, Technion Institute of Technology, Faculty of Medicine.
1994-1999: Senior lecturer, Technion Institute of Technology, Faculty of Medicine.
1992-1996: Senior lecturer, Tel-Aviv University, Sackler School of Medicine, Dept. of  surgery, section of Urology.
1983-1992: Instructor, Tel-Aviv University, Sackler School of Medicine, Department of surgery, Section of Urology.

Professional Expirience:

1973-1976: Medical studies: Faculta de Medicina e Chirurgia, Universita de Milano, Italy.
1976-1979: Medical studies: Tel-Aviv University, Sackler school of Medicine. MD Thesis: A review of patients with hypernephroma at Beilinson Hospital between
1968-1979: (supervisors - Prof. C. Servadio, Dr. E. Mukamel).
July, 1981: M.D. degree, Tel-Aviv University, Medical license no.-14836
1979-1980: Rotating internship, Hasharon Hospital, Petah-Tiqva.
1981-1982: Resident, Dept. Urology, Sheba Medical Center (Head of Dept., Prof. M. Manny)
1982-1984: Rotating residency, Dept. General Surgery & Transplantation, Sheba Medical Center, (Head of Dept., Prof. E.T. Jacob).
1984-1985: Experimental research, Dept. Cell Biology, Sackler School of Medicine. (Supervisor, Prof. M. Aronson).
1985-1986: Chief resident, Dept. Urology, Sheba Medical Center (Head of Dept., Prof. M. Manny).
1986-1987: Rotating residency, Dept Obstetrics & Gynecology, Sheba Medical Center. (Head of Dept., Prof. S. Mashiach).
Dec. 1987: Receipt of Specialization Certificate, no. 09588.
1981-1987: Tel-Aviv University, Sackler School of Medicine, Postgraduate Medical School, MSc in Urology.
1987-1989: Research fellow, Urology research laboratory, Mayo Clinic, Rochester, MN. (Supervisor, Prof. M.M. Lieber).
1987-1988: Course in Biostatistics. Rochester, MN, USA.
1988: Course in Endouroliogical Surgery. Minneapolis, MN, USA.
1989: Course in Prostate Ultrasound. Atlanta, GA, USA.
1989 : Course in Microvascular Surgical Techniques. Rochester, MN, USA
1989-1990: Clinical fellow, Urologic Service, Memorial Sloan-Kettering Cancer Center, New York, NY (Chief, Prof. W.R. Fair).
1990-1993: Senior Consultant, Dept. Urology, Sheba Medical Center. (Head of Dept. Prof. B. Goldwasser).
Since 1993: Head Dept. Urology, Bnai Zion Medical Center, Haifa.

Research Interests:

  • Experimental therapeutic agents for superficial bladder cancer.
  • Flow cytometeric nuclear DNA analysis of genitourinary malignancies.
  • Morphometric characterization of genitourinary neoplasms.
  • Development of surgical techniques and devices for the management of urinary incontinence.
  • Noninvasive detection of bladder cancer by means of proteomic and metabolomic analysis.
  • Improving drug delivery for treatment of superficial bladder cancer.
  • Assessment the role of tissue adhesives in nephron sparing surgery.
  • Functional preservation in nephron sparing surgical procedures.
  • Ischemic damage to the kidney during nephron sparing surgery.

Public Professional Activities:

1991-2011: Member of the committee for examinations in urology, Israel Medical Association, Scientific council.
Since 1991: Member of the national board of examiners in urology.
Since 1992: Expert reviewer for Urology.
Since 1993: Expert reviewer for International Journal of Cancer.
1994-2000: Member of the research committee, faculty of medicine, Technion.
Since 1995: Member of the specialization committee, Israel Medical Association, scientific council.
Since 1996: Expert reviewer for cancer.
1996-2000: Member of the executive committee of the Israeli Urological Association.
Since 1998: Expert reviewer for European Urology
Since 2000: Expert reviewer for IMAJ
Since 2000: Member of the Urologic-Oncology committee of the Israel Cancer Association.
Since 2004: Member of the editorial board of IMAJ.
Since 2000: Experts reviewer for the Journal of Urology
Since 2006: Expert reviewer Urologic Oncology.
Since 2005: Expert reviewer for grant application to the Israeli Ministry of health.
Since 2008: Member of cancer prevention committee, Israel Cancer Association.
Since 2010: Expert reviewer for Scandinavian Journal of Urology & Nephrology.
Since 2010: Member of the editorial board and reviewer WJUR.

Conferences and Invited Talks:

  • Nativ O.: Static Image Cytometry for Measurement of Nuclear DNA Content from Pre-Operative Prostate Needle Biopsy Specimens.   AUA, New York, NY, 1990.
  • Nativ O.: Premalignant Lesions of the Bladder: Diagnosis and Treatment. SFU. Nantes, France, 1991.
  • Nativ O.: Nephron Sparing Surgery for Renal Cell Carcinoma. European School of Oncology, Jerusalem, Israel, 1997.
  • Nativ O.: New Surgical Techniques for the Management of Female Incontinence. ICS. Yokohama,  Japan, 1997.
  • Nativ O.: Incisionless Transvaginal Bone Anchor Sling Procedure.   Genoa, Italy, 1998.
  • Nativ O.: Bone Anchor Male Sling for Post Prostatectomy Incontinence, Hamburg, Germany, 1999.
  • Nativ O.: Co-Chairman Session on Basic Research for Urothelial Cancer, EAU, Paris, France, 2006.
  • Schulman C., Kirkaly Z., Nativ O.: EAU Panel on Case Management in Kidney Cancer. Eilat, Israel, 2007.
  • Nativ O.: The Advantages of Open Approach in Nephron Sparing Surgery. CURY , Barcelona, Spain, 2008.
  • Nativ O.: The Case for Conservative Approach in the Management of BCG Failure Patients. CURY, Barcelona, Spain, 2008.
  • Nativ O.: Update on Screeining and Early Detection of Prostate Cancer. Sanofi-Aventis Meeting, Kfar Blum, Israel, 2008.
  • Nativ O.: What is Left for Open Nephrectomy. CURY, Lisbon Portugal, 2009. 
  • Nativ O.: The Advantages of Open Nephron Sparing Surgery. CURY, Lisbon Portugal, 2009.
  • Nativ O.: Experience with Synergo Treatment in NMIBC and Conservative Approach for High Risk Bladder Cancer. Meeting of the German Urological Association, Giessen, Germany, 2010.
  • Nativ O.: Current Treatment Options for Metastatic RCC: The Role of the Urologist. Israel Urological Association Meeting, Eilat, Israel, 2011.
  • Nativ O.: The Role of Endocrine Treatment in Localized Prostate Cancer. Israel Urological Association Meeting, Eilat, Israel,  2011.
  • Nativ O: Importance of Renal Function Preservation during Nephron Sparing Surgery. FOIU, Tel Aviv, Israel,  2012
  • Nativ O: Renal Surgery. International Robotic and Open Surgery Symposium, USC Institute of Urology, LA, USA, 2013.
  • Nativ O: Predicting Progression of Bladder Urothelial Carcinoma using microRNA Expression. WCC, Nanjing, China, 2014.

 

Research & Publications:

Show more publications
Medical Consultation

One of our medical consultants will call you within 2 hours.

The name field is required.
The phone field must be at least 10 digits.
Please enter a valid email address.
The message field is required.

Processing...

All information is strictly confidential and will never be disclosed to third parties.